ESTEVE PHARMACEUTICALS
Live / Registered — Registered (as of 13 Jan 2026)
What this means for you
Registered since 13 Jan 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99044353
- Registration number
- 8099251
- Mark type
- Stylized text
- Filed
- 17 Feb 2025
- Published for opposition
- 25 Nov 2025
- Registered
- 13 Jan 2026
- Attorney of record
- G Patrick SAGE II
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of metabolic disorders, namely, for treating diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism; Pharmaceutical preparations for the treatment of the endocrine system, namely, for treating growth and thyroid disorders; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, for treating connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, and cartilage injuries; Pharmaceutical preparations for the treatment of genitourinary diseases, namely, for treating urological diseases, infertility, sexually transmitted diseases, and inflammatory pelvic diseases; Pharmaceutical preparations for the treatment of neurological diseases, namely, for use in treating Alzheimer's disease, Huntington's disease, cerebral palsy, brain injuries, spinal cord injuries, and seizure disorders; Pharmaceutical preparations for the treatment of hormonal disorders, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, and thyroid hormone preparations; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, for treating mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; Pharmaceutical preparations for the treatment of cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, and immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology, namely, for use in treating dermatitis, eczema, psoriasis, skin pigmentation diseases, and dermatological sexually transmitted diseases
Owner
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
Prosecution history
- 13 Jan 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Jan 2026 — REGISTERED-PRINCIPAL REGISTER
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Oct 2025 — EXAMINER'S AMENDMENT ENTERED
- 27 Oct 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 Oct 2025 — EXAMINERS AMENDMENT E-MAILED
- 27 Oct 2025 — EXAMINERS AMENDMENT -WRITTEN
- 24 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Jul 2025 — NON-FINAL ACTION E-MAILED